Skip to main content
UploadLanguage (EN)Support
BusinessMobileSocial MediaMarketingTechnologyArt & PhotosCareerDesignEducationPresentations & Public SpeakingGovernment & NonprofitHealthcareInternetLawLeadership & ManagementAutomotiveEngineeringSoftwareRecruiting & HRRetailSalesServicesScienceSmall Business & EntrepreneurshipFoodEnvironmentEconomy & FinanceData & AnalyticsInvestor RelationsSportsSpiritualNews & PoliticsTravelSelf ImprovementReal EstateEntertainment & HumorHealth & MedicineDevices & HardwareLifestyle
Dr. Advaitha MV, profile picture
Uploaded byDr. Advaitha MV
PPTX, PDF37,807 views

Screening Methods of Antihypertensive Agents

This document discusses preclinical screening methods for antihypertensive agents using animal models of hypertension. It describes several animal models that mimic different types of human hypertension, including renovascular hypertension induced by clipping the renal artery, dietary hypertension from high salt intake, and genetic hypertension using spontaneous hypertensive rats. The ideal animal model criteria are outlined as well as common methods for measuring blood pressure directly via catheterization or indirectly via tail-cuff. The effects of different classes of antihypertensive drugs are also reviewed.

Health & Medicine◦
Downloaded 1,470 times
Preclinical screening methods of Antihypertensive agents (for MD Pharmacology) - Dr. Advaitha M V
Introduction • The animal models of hypertension share many features which are common to human hypertension. • Many of these models have been developed by utilizing the etiological factors that are presumed to be responsible for human hypertension. Excessive salt intake. Hyperactivity of renin-angiotensin- aldosterone system (RAAS) and Genetic factors.
An ideal animal model of hypertension criteria • It should be feasible in small animals. • Simple to perform and uniformly reproducible. • Should be able to predict the potential antihypertensive properties of an agent. • Consume minimal quantities of compounds. • It should be comparable to some form of human hypertension.
Animals used • In the past, most studies on experimental hypertension were carried out on Dogs. • Currently, rat is the preferred animal species. • Spontaneous hypertensive rat (SHR), the genetic strain of hypertensive rat, is the animal of choice.
Types of animal models of hypertension 1. Renovascular hypertension 2. Dietary hypertension 3. Endocrine hypertension 4. Neurogenic hypertension 5. Psychogenic hypertension 6. Genetic hypertension 7. Other models
1. Renovascular Hypertension
• This is a very commonly used model of hypertension. • Experimentally, renal hypertension is produced by constriction of renal artery. • This activates peripheral RAAS and sympathetic nervous system.
Methods of inducing renovascular hypertension Goldblatt method: Goldblatt et al (1934) • He reported that a partial constriction of renal arteries in dogs produced hypertension. • This type of hypertension has also been induced in rabbits, rats and monkeys.
• Rats weighing from 120 to 200 g are anaesthetized with hexobarbitone sodium (40 mg/kg body weight). • A silver clip of 0.2 mm internal diameter is placed on the left renal artery close to the aorta. • The renal artery in rats can also be ligated with 4-0 silk suture.
• Constriction of renal artery should be more than 50%. • The animal is considered hypertensive if systolic BP is more than 160 mm Hg for two consecutive days after 4 weeks of ligation/application of clip.
• Three variants of hypertension produced by Goldblatt method- • Two kidney one clip (2K1C) hypertension • One kidney one clip (1K1C) hypertension • Two kidney two clip (2K2C) hypertension
Two kidney one clip (2K1C) hypertension • The renal artery is constricted on only one side with the other artery (or kidney) left untouched. • This results in a sustained increase in BP. • Initially , there is no salt and water retention because of the other normal kidney being intact. • So , the resultant hypertension at this stage is renin-angiotensin dependent.
• After about 6 weeks, the increased angiotensin- II releases aldosterone from adrenal cortex leading to gradual retention of salt and water. • Retention of salt and water leads to decreased renin production. • From this stage onwards, hypertension is volume dependent.
One kidney one clip (1K1C) hypertension • Constriction of renal artery is done on one side and the contra lateral kidney is removed. • There is an increase in BP within a few hours. • Since there is no contra lateral kidney, there is no pressure diuresis and natriuresis.
• So there is rapid salt and water retention. • Plasma renin activity is usually normal. • Hypertension soon becomes volume dependent
Two kidney two clip (2K2C) hypertension • Constriction of aorta or both renal arteries is done. • There is a patchy ischemic kidney tissue, which secretes renin leading to increased BP. • The remaining kidney tissue retains salt and water. • one of the most common causes of renal hypertension in human beings is (such) a patchy ischaemic kidney disease.
Hypertension induced by external compression of renal parenchyma Grollman hypertension • In this method, kidney tissue is compressed by securing a 'figure of 8' ligature. • It is of two types: • Two kidney one ligature (2K1L) • One kidney one ligature (1K1L)
Reduced renal mass • Reducing renal tissue to five-sixth (5/6th) by renal mass ablation produces hypertension. • Here , the right kidney is removed and 2 or 3 branches of left renal artery are ligated. • This is to produce infarction of approximately 2/3rd of the left kidney.
2. Dietary hypertension:
I. Increased salt intake: • Chronic ingestion of excess salt produces hypertension in rats, which mimics human hypertension morphologically. • High salt intake hypertension has been produced in rats, rabbits and chicks by replacing drinking water with 1-2% sodium chloride for 9- 12 months.
• This method is also used to cause Accelerated high pressure in renal hypertension.
3. Endocrine hypertension
DOCA-Salt induced HTN • Selye et al was the first to demonstrate that deoxycorticosterone acetate (DOCA) produces hypertension in rats. • There is increased DOCA-induced reabsorption of salt and water leading to increased blood volume and hence increased BP. • There is also increased secretion of vasopressin leading to water retention and vasoconstriction.
• In addition, altered activity of RAAS leads to increased sympathetic activity • Rats, especially female and young, are prone to DOCA-salt induced hypertension. • DOCA induced hypertension is salt dependent (neither administration of DOCA nor partial removal of renal mass is effective in increasing BP when applied without salt Administration).
To produce hypertension, • Rats weighing about 100 g are kept on a diet high in sodium chloride and drinking water is replaced by 2% sodium chloride solution. • After they attain a weight of about 250 g, they are given DOCA dissolved in sesame seed oil at a dose of 10 mg/kg SC, twice weekly for 4 weeks.
4. Neurogenic hypertension
• One of the most important negative feedback in the control of BP originates from baroreceptors in the carotid sinus and aortic arch. • Afferents of baroreceptors travel along 9th and 10th cranial nerves. • Sectioning of the baroreceptor nerves leads to persistent rise in BP. • Suitable in dogs, cats and rabbits
5. Psychogenic hypertension
• Repeated exposure to stressful situation may lead to a state of persistent hypertension. • Borderline hypertensive rats (BHR) are useful for psychogenic hypertension. • BHRs that were exposed to daily sessions of either short (20 min) or long (120 min) duration air-jet stimulation developed hypertension within 2 weeks.
• Stress plays an important part in development of human hypertension. • So, This model is also very frequently used to study the pathophysiology of hypertension.
6. Genetic hypertension
• The so called ‘spontaneous hypertensive rat (SHR)’ was developed by meticulous genetic inbreeding by Okamoto and Aoki. • This inbreeding resulted in 100% of the progeny having naturally occurring hypertension
How are SHR ? • In SHRs, BP gradually increases until it is maintained at a markedly elevated level after approximately 12 weeks of age. • In unrestrained male SHRs, mean arterial pressure is approximately 190- 200 mm Hg as compared to 115-130 mm Hg in normal rats.
• During the early stable stages and developmental phase of hypertension- elevated BP is maintained in large part by enhanced central sympathetic outflow. • In the later stages Increased total peripheral resistance. normal cardiac output decreased permeability of the glomerular membranes Forms the basis for the long term maintenance of the hypertension
• SHRs also develop typical complications of hypertension. • There are Stroke prone SHRs (SHRSP), which are selectively bred among SHRs. • These develop cerebrovascular lesions spontaneously in over 80% of rats.
• Because of apparent similarities of the SHR to essential hypertension- SHR models are highly recommended for screening potential drug candidates for hypertension
• Other models
Obesity-related hypertension • Wistar fatty rats (WFR) are derived from cross between obese Zucker and Wistar Kyoto rats. • These show persistent hyperinsulinemia and hypertension after 16 weeks of age. • A good model to elucidate the relationship between hyperinsulinemia and hypertension.
Wistar Kyoto Rat
Transgenic rat (TGR) models • Transgenic models of hypertension have revolutionized the experimental work on hypertension. • Here , an additional renin gene, the murine Ren-2 gene, is introduced into the germ line of rats. • This results in transgenic hypertensive rat strain, TGR (mREN2). • It has an overexpression of renin.
• Linkage has been described for the angiotensinogen gene in human hypertension. • TGR model are also useful for studying the role of local RAAS system in hypertension.
Others • Angiotensin-II induced hypertension. • Hypertension induced by cadmium • Chronic nitric oxide inhibition-induced hypertension.
How to measure BP ? Direct Method : • It is a invasive procedure. • A week before the drug adminstration, The animals are anesthetized. • Femoral/Carotid Cannula is inserted. • On the day of screening, cannula is connected to a mercury manometer or a pressure transducer. • BP is measured
In rats • A week before the experiment, each rat is anaesthetised with 40 mg/kg pentobarbital. • Left or right carotid artery or femoral artery is cannulated under aseptic conditions with polyethylene cannula filled with 1% heparin in normal saline. • Free end of the cannula is passed under the skin and allowed to protrude 3-4 cm from the skin behind the ears of the rat.
• The skin incisions are sutured and a plastic skin dressing is applied. • After recovery from anaesthesia (2-2.5 h) each rat is placed in an individual cage for 24 h habituation period
• On the day of expt., Cannula is connected to a pressure transducer then to the pre-amplifier. • BP is recorded on the polygraph or physiograph.
Non-Invasive/ Indirect method : In rats Tail cuff Method : • It is a common and convenient method. • Tail cuff is inflated and then deflated. • Pulsations disappear when cuff is inflated. • When cuff is deflated, pulsations start appearing when pressure in the cuff equals systolic pressure.
• The cuff is attached to a tail cuff sphygmomano-meter or pressure transducer and BP is recorded on a chart. • Tail swelling method. • Foot swelling method.
Effects of antihypertensive agents • Antihypertensive drugs, according to their mode of action, will affect the blood pressure in certain types of experimental hypertension, and not in all ! • Vasodilators like minoxidil, hydralazine and diazoxide are effective in renal hypertensive rats.
• CCB, ACE inhibitors and AT-1 antagonists decrease BP in 5/6 nephrectomised SHR • Diuretics, are active in mineralocorticoid or salt induced hypertension. • Sympathomimetic Drugs decrease BP in both endocrine and neurogenic hypertension.
An E.g. of data collection
Invitro models • Endocrine receptor antagonism in porcine isolated heart • Monocrantaline-induced pulmonary hypertension.
References • D.K. BADYAL, H. LATA , A.P. DADHICH. ANIMAL MODELS OF HYPERTENSION AND EFFECT OF DRUGS. Indian Journal of Pharmacology 2003; 35: 349-362. • Journal of Visualized Experiments videos Video downloads from http://www.ncbi.nlm.nih.gov/pmc/articles/P MC2794298/bin/jove-27-1291.flv http://www.ncbi.nlm.nih.gov/pmc/articles/P MC3462562/bin/jove-59-3496.mov
Thank You